Abstract
Atherosclerosis is a multifactorial disease that is caused by many years of exposure to atherogenic stimuli that already at a young age lead to early lesions, the so-called "fatty streaks". One of the mechanisms involved in atherogenesis is the activated blood coagulation system, but its primary role in this process has not been established. From the fatty streak onwards, evidence of activated coagulation is histologically present in the form of fibrin/fibrinogen molecules. With advancing lesions, the presence of tissue factor protein, introduced by invading macrophages or locally expressed by vascular smooth muscle cells (VSMC) becomes more prominent. Tissue factor has been shown to be an important agonist of arterial thrombosis upon erosion of the luminal plaque surface or frank rupture of plaques. Recent data indicate the production of factor VII, probably expressed by VSMC in plaque lesions, which raises the possibility that formation of a catalytic tissue factor/factor VIIa complex occurs in the atherosclerotic vessel wall. Theoretically, such a complex could then induce local generation of thrombin and fibrin molecules, but its precise role is still unknown. While fibrinogen/fibrin molecules participate in early plaque lesions, increased activity of systemic coagulation is of no major influence on the risk of arterial thrombosis, except in rare cases where a number of specific procoagulant forces collide. Despite the presence of tissue factor - factor VII complex it is unlikely that all fibrin in the atherosclerotic plaque is the direct result from local clotting activity. Evidence is accumulating that the tissue factor/factor VII complex is involved in important coagulation-independent biological processes (inflammation, cell migration, apoptosis), either via direct signal transduction through tissue factor or by (in)direct activation of protease activated receptors. The presence of localized vascular "mini-cascades" of coagulation proteins may target a new role of coagulation in vessel wall remodeling and plaque vulnerability.
Keywords: Coagulation, atherothrombosis, atherosclerosis, thrombin, fibrinogen
Current Genomics
Title: Blood Coagulation and the Risk of Atherothrombosis
Volume: 6 Issue: 6
Author(s): H. M.H. Spronk and H. T. Cate
Affiliation:
Keywords: Coagulation, atherothrombosis, atherosclerosis, thrombin, fibrinogen
Abstract: Atherosclerosis is a multifactorial disease that is caused by many years of exposure to atherogenic stimuli that already at a young age lead to early lesions, the so-called "fatty streaks". One of the mechanisms involved in atherogenesis is the activated blood coagulation system, but its primary role in this process has not been established. From the fatty streak onwards, evidence of activated coagulation is histologically present in the form of fibrin/fibrinogen molecules. With advancing lesions, the presence of tissue factor protein, introduced by invading macrophages or locally expressed by vascular smooth muscle cells (VSMC) becomes more prominent. Tissue factor has been shown to be an important agonist of arterial thrombosis upon erosion of the luminal plaque surface or frank rupture of plaques. Recent data indicate the production of factor VII, probably expressed by VSMC in plaque lesions, which raises the possibility that formation of a catalytic tissue factor/factor VIIa complex occurs in the atherosclerotic vessel wall. Theoretically, such a complex could then induce local generation of thrombin and fibrin molecules, but its precise role is still unknown. While fibrinogen/fibrin molecules participate in early plaque lesions, increased activity of systemic coagulation is of no major influence on the risk of arterial thrombosis, except in rare cases where a number of specific procoagulant forces collide. Despite the presence of tissue factor - factor VII complex it is unlikely that all fibrin in the atherosclerotic plaque is the direct result from local clotting activity. Evidence is accumulating that the tissue factor/factor VII complex is involved in important coagulation-independent biological processes (inflammation, cell migration, apoptosis), either via direct signal transduction through tissue factor or by (in)direct activation of protease activated receptors. The presence of localized vascular "mini-cascades" of coagulation proteins may target a new role of coagulation in vessel wall remodeling and plaque vulnerability.
Export Options
About this article
Cite this article as:
Spronk M.H. H. and Cate T. H., Blood Coagulation and the Risk of Atherothrombosis, Current Genomics 2005; 6 (6) . https://dx.doi.org/10.2174/138920205774483043
DOI https://dx.doi.org/10.2174/138920205774483043 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Advanced AI Techniques in Big Genomic Data Analysis
The thematic issue on "Advanced AI Techniques in Big Genomic Data Analysis" aims to explore the cutting-edge methodologies and applications of artificial intelligence (AI) in the realm of genomic research, where vast amounts of data pose both challenges and opportunities. This issue will cover a broad spectrum of AI-driven strategies, ...read more
Applications of Single-cell Sequencing Technology in Reproductive Medicine
Single cell sequencing (SCS) technology utilizes individual cells' genetic material to sequence their genome, transcriptome, and epigenetics at the molecular level. It offers insights into cell heterogeneity and enables the study of limited biological materials. Since its recognition as a valuable technique in 2011, single cell sequencing has yielded numerous ...read more
Big Data in Cancer Research
Cancer is a significant threat to human life and health, remaining a highly aggressive killer. It is a leading cause of death worldwide and represents a crucial medical issue for humanity. However, in the past decade, the effectiveness of new synthetic anticancer agents has not matched the current clinical speculation. ...read more
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Current Paradigms in COVID-19 Research: Proposed Treatment Strategies, Recent Trends and Future Directions
Current Medicinal Chemistry Current Therapeutic Strategies and Future Perspectives for the Prevention of Arterial Thromboembolism: Focus on Atrial Fibrillation
Current Pharmaceutical Design Edaravone (3-Methyl-1-Phenyl-2-Pyrazolin-5-one), A Novel Free Radical Scavenger, for Treatment of Cardiovascular Diseases
Recent Patents on Cardiovascular Drug Discovery Frailty of Older Age: The Role of the Endocrine - Immune Interaction
Current Pharmaceutical Design What Does the Future Hold for Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis?
Current Vascular Pharmacology Top Three Pharmacogenomics and Personalized Medicine Applications at the Nexus of Renal Pathophysiology and Cardiovascular Medicine
Current Pharmacogenomics and Personalized Medicine Protective Role of Italian Juglans regia L. nut Ethanolic Extract in Human Keratinocytes under Oxidative and Inflammatory Stress
Current Pharmaceutical Biotechnology Applied Proteomics in Companion Animal Medicine
Current Proteomics Duration of Dual Antiplatelet Therapy After Coronary Stenting
Current Pharmaceutical Design Impact of Different Soil Enrichments on the Physicochemical and Antioxidant Potential of Red and White Calyx from Roselle (Hibiscus sabdariffa L.)
Current Nutrition & Food Science Molecular Targets of Rheumatoid Arthritis
Inflammation & Allergy - Drug Targets (Discontinued) Host Neuro- Immuno-Endocrine Responses In Periodontal Disease
Current Pharmaceutical Design Cardiac Oxidative Stress and Inflammatory Cytokines Response after Myocardial Infarction
Current Vascular Pharmacology Association of Zinc and Copper Status with Cardiovascular Diseases and their Assessment Methods: A Review Study
Mini-Reviews in Medicinal Chemistry Uteroplacental Circulation and Fetal Vascular Function and Development
Current Vascular Pharmacology Recent Patents in Olive Oil Industry: New Technologies for the Recovery of Phenols Compounds from Olive Oil, Olive Oil Industrial by-Products and Waste Waters
Recent Patents on Food, Nutrition & Agriculture Substrate Binding and Kinetic Aspects of the Peroxidation Reaction of Four Polyunsaturated Fatty Acids in the COX Active Site of PGHS-1
Letters in Drug Design & Discovery Inflammatory Markers in Cardiovascular Disease; Lessons Learned and Future Perspectives
Current Vascular Pharmacology Advanced Glycation: How are we Progressing to Combat this Web of Sugar Anomalies in Diabetic Nephropathy
Current Pharmaceutical Design Therapeutic Targets for Management of Periodontitis and Diabetes
Current Pharmaceutical Design